Treatment for stomach cancer depends mostly on its stage and, for advanced disease, on biomarkers such as HER2. This Stomach Cancer Awareness Month explainer walks through the main options at each stage, based on National Cancer Institute guidance.
|Articles|January 20, 2010
Help Drew Carey give his money to the Lance Armstrong Foundation
Author(s)Melissa Weber
Advertisement
Drew Carey really wants to give the Lance Armstrong Foundation a million bucks. Last fall, the actor and host of The Price Is Right said he would donate $1 million to LAF if his @DrewFromTV Twitter account reached a million followers before the ball dropped on New Year's Eve.Then, in a tweet on December 30, he changed the rules: Follow him or LAF's @LIVESTRONG Twitter account and when the combined number of followers hits one million – regardless of the date – a check for as much is in the mail.As of this post,
Advertisement
Related to this article
A mother whose daughter is seven years past breast cancer treatment shares how scan anxiety and waiting shape life after cancer for survivors and families.
A review of 29 studies in more than 22,000 women 65 and older with ER-positive breast cancer found no statistically significant survival difference between hormone therapy alone and surgery first, though surgery controlled the cancer in the breast better.
The FDA approved Imfinzi plus Padcev before and after surgery for adults with muscle-invasive bladder cancer who cannot or will not receive cisplatin.
Anxiety before a scan and while waiting for results is common for people with cancer and survivors. These five steps, drawn from ASCO, the American Cancer Society and the National Cancer Institute, can make the wait easier.
For Lung Cancer Awareness Month, five numbers from federal and American Cancer Society data show how survival for people with lung cancer has changed, how it differs by stage and type, and how many people are living with the disease.
A 12-year breast cancer survivor with 16 tattoos, including radiation marks, weighs new research on tattoos and lymphoma risk and the questions it prompts.
An Ohio State hematologist discusses a new trial comparing tovorafenib plus rituximab with standard cladribine-based treatment, and what quality of life means for patients.
Advertisement
Advertisement
Trending on CURE
1
5 Ways to Cope With Scanxiety While Waiting for Cancer Results
2
5 Lung Cancer Survival Numbers Patients Should Know in 2026
3
Living in the After: A Mom's View of Breast Cancer Survivorship
4
Medicare Part D 2027: What a $2,400 Cap Means for Cancer Drugs
5